CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches September 26, 2016December 14, 2022 Arthur N. Brodsky, PhD
CICON16: Translating Science Into Survival September 24, 2016December 14, 2022 Arthur N. Brodsky, PhD
CRI Congratulates 2016 Lasker Award Winners September 14, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer August 8, 2016December 14, 2022 Alexandra Mulvey